Maria P. Amato

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 345 publications

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 28, 2026

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 21, 2026

Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition.

Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition.

Journal: Nature reviews. Neurology

Published: July 09, 2026

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

Cognitive impairment in multiple sclerosis: Where do we stand today?

Cognitive impairment in multiple sclerosis: Where do we stand today?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 23, 2026

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Journal: Neurology

Published: May 29, 2026

Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Journal: Journal of neurology

Published: May 18, 2026

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.

Journal: Neurorehabilitation and neural repair

Published: April 25, 2026

Cognition in multiple sclerosis.

Cognition in multiple sclerosis.

Journal: Current opinion in neurology

Published: April 10, 2026

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Journal: Brain : a journal of neurology

Published: March 12, 2026

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal: Journal of neurology

Published: March 02, 2026

Showing 1-12 of 345

Last Updated: 09/26/2026